Ideaya Biosciences, Inc. · NASDAQ:IDYA
Ideaya Biosciences — Fact Sheet (May 2025)
2 slides from Ideaya Biosciences's fact sheet, May 2025
Slide 1: IDEAYA Highlights
IDEAYA Highlights Breakthrough Science on transformative programs in precision medicine, including Synthetic Lethality – May 2025 an emerging area of precision medicine Broad Pipeline of potential first-in-class precision medicine oncology programs with defined patient biomarkers Proven Management T
Slide 2: IDEAYA Biosciences – Fact Sheet
IDEAYA Biosciences – Fact Sheet Founded 2015 on the thesis that Synthetic Lethality would emerge as a central focus of precision medicine oncology, with significant Pharma interest and the potential to develop first-in-class therapeutics for biomarker-defined cancer patient populations. Broad Pipeli